Prognostic factor of nivolumab for advanced gastric cancer patients with poor performance status patients.

Toshihiko Matsumoto,Ukyo Okazaki,Yusuke Kurioka,Shogo Kimura,Takao Tsuzuki,Shinjiro Takagi,Masahiro Takatani,Hirofumi Morishita

Prognostic factor of nivolumab for advanced gastric cancer patients with poor performance status patients.

2020

Toshihiko Matsumoto
Ukyo Okazaki
Yusuke Kurioka
Shogo Kimura
Takao Tsuzuki
Shinjiro Takagi
Masahiro Takatani
Hirofumi Morishita

391Background: Nivolumab has changed the treatment of advanced gastric cancer (AGC). Nivolumab shows better outcome compared to best supportive care in AGC patients who received at least two prior ...

Keywords:

Cancer
Nivolumab
Internal medicine
prognostic factor
Poor performance status
Physical therapy
Medicine
Oncology
advanced gastric cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations